Streetbeat News

MIRA

MIRA Pharmaceuticals, Inc.

Industry

Drug Manufacturers - General

MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. It is developing MIRA1a, a synthetic cannabinoid analog to treat anxiety and chronic pain by targeting the cannabinoid type 1 and type 2 receptors. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Baltimore, Maryland.

Open

1.28

Mkt cap

21M

Volume

357K

High

1.33

P/E Ratio

-2.40

52-wk high

5.01

Low

1.23

Div yield

N/A

52-wk low

0.51

Shares of MIRA Pharmaceuticals were halted on a circuit breaker to the upside, with the stock now up by 70.7%.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2023 | 3:30 pm

Mira Pharmaceuticals has shared data and research that positions its product, MIRA1a, as a potential future alternative prescription medication with properties not found in THC. The company suggests that MIRA1a could have fewer side effects.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2023 | 12:36 pm

During Friday's session, 169 companies set new 52-week lows. Among them, Bristol-Myers Squibb was the largest firm by market cap to set a new 52-week low, while Blue Star Foods was the smallest. PTC Therapeutics' stock fell the most, trading down 31.29% to reach a new 52-week low. Meanwhile, Prelude Therapeutics' stock bounced back the most, rising 0.0% after reaching its new 52-week low.

Portfolio Pulse from Benzinga Insights

September 15, 2023 | 3:52 pm

During Wednesday's intraday session, several healthcare stocks experienced significant movements. Avalo Therapeutics, Impel Pharmaceuticals, ZyVersa Therapeutics, Rocket Pharmaceuticals, Novo Integrated Sciences, and Nemaura Medical saw their stocks rise by 54.3%, 51.99%, 40.46%, 36.88%, 32.16%, and 27.14% respectively. On the other hand, Eiger BioPharmaceuticals, Longeveron Inc. - Subscription Right, Mira Pharmaceuticals, Infinity Pharmaceuticals, Creative Medical Tech, and cbdMD saw their stocks fall by 44.6%, 37.16%, 23.73%, 17.56%, 16.4%, and 14.29% respectively.

Portfolio Pulse from Benzinga Insights

September 13, 2023 | 5:31 pm

Shares of Tenon Medical, Inc. (TNON), Axcella Health Inc. (AXLA), Courtside Group, Inc. (PODC), Impel Pharmaceuticals Inc. (IMPL), MIRA Pharmaceuticals, Inc. (MIRA), Nuwellis, Inc. (NUWE), Hitek Global Inc. (HKIT), WANG & LEE GROUP, Inc. (WLGS), AEye, Inc. (LIDR), and Magenta Therapeutics, Inc. (MGTA) are trading lower in pre-market. The drop in TNON's shares is due to a proposed public offering of common stock.

Portfolio Pulse from Lisa Levin

September 11, 2023 | 12:10 pm

During Thursday's pre-market session, several healthcare stocks experienced significant movement. Asensus Surgical, China SXT Pharmaceuticals, CymaBay Therapeutics, CervoMed, Mira Pharmaceuticals, and China Pharma Holding saw increases in their share prices. Conversely, Palisade Bio, NeuBase Therapeutics, Aeglea BioTherapeutics, Inspire Veterinary, Heart Test Laboratories, and Trevena experienced declines.

Portfolio Pulse from Benzinga Insights

September 07, 2023 | 1:06 pm

Several stocks have shown significant movement in pre-market trading. WestRock Company (NYSE:WRK) gained 11.6% as it is nearing a deal to merge with Smurfit Kappa. Other gainers include American Rebel Holdings, Inc. (NASDAQ:AREB), Artelo Biosciences, Inc. (NASDAQ:ARTL), and Wheeler Real Estate Investment Trust, Inc. (NASDAQ:WHLR). On the other hand, Sportsman's Warehouse Holdings, Inc. (NASDAQ:SPWH) fell 25.8% after posting downbeat Q2 results. Other losers include NeuBase Therapeutics, Inc. (NASDAQ:NBSE), Verint Systems Inc. (NASDAQ:VRNT), and Yext, Inc. (NYSE:YEXT).

Portfolio Pulse from Lisa Levin

September 07, 2023 | 12:10 pm

MIRA Pharmaceuticals and MZ Group have announced a partnership to enhance investor relations and shareholder communication efforts. The partnership aims to improve transparency and engagement with shareholders.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2023 | 12:55 pm

On Monday, 149 companies reached new 52-week lows. The largest company by market cap to hit a new 52-week low was NextEra Energy (NYSE:NEE), while the smallest was Esports Entertainment (NASDAQ:GMBL). Bionano Genomics (NASDAQ:BNGO) saw the most pronounced move, with shares trading down 842.14% to hit its new 52-week low. Northwest Natural Hldg (NYSE:NWN) shares gained 0.0%, rebounding after it reached its 52-week low.

Portfolio Pulse from Benzinga Insights

August 07, 2023 | 4:13 pm

Pre-clinical-stage biopharma company, MIRA Pharmaceuticals, has launched its initial public offering on NASDAQ. The company is developing a synthetic THC prescription drug, MIRA1a, to treat anxiety, pain, and cognition disorders without the side effects of cannabis or opioids. If approved by the FDA, MIRA1a could advance the treatment of neuropsychiatric, inflammatory, and neurologic diseases and disorders.

Portfolio Pulse from Nina Zdinjak

August 04, 2023 | 1:56 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.